Trump Nominates RFK Jr. as Head of Health and Human Services
Shares of vaccine-makers Moderna and Pfizer fell after reports that Donald Trump is expected to nominate vaccine skeptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services. Moderna's stock fell 5.6% and Pfizer was down 2.6%. The news caused a decline in other vaccine-maker stocks as well, with BioNTech, Novavax, and Vaxcyte all experiencing losses. Trump's decision to appoint RFK Jr. was met with mixed reactions, with Kennedy emphasizing that vaccines will not be taken away from anyone. The announcement came after the market's close, and Trump expressed his belief that the industrial food complex and drug companies have engaged in deception and misinformation regarding public health.